AEON Biopharma, Inc. - Class A Common Stock (AEON)

CUSIP: 00791X209

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 5 signals
Share change
+1,526,776
SEC-reported price per share
$0.58
Number of holders
15
Value change
+$884,785
Number of buys
15
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
50,000,000

Security key

00791X209

Report period

Q1 2025

Institutions

15

Top holders

10

Ownership snapshot

Top reported holders of AEON - AEON Biopharma, Inc. - Class A Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Dauntless Investment Grou...
Disclosed value leader
Priveterra Sponsor, LLC
Comparable rows
5/15
Latest evidence
31 Mar 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.7% 10 rows are not safely comparable across share classes. 13D/G row: Dauntless Investment Group, LLC Showing 1-6 of 15 holder rows.

Quick read

Dauntless Investment Group, LLC leads the comparable SEC ownership view at 9.7%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Dauntless Investment Group, LLC's linked filing trail.
Comparable ownership Top 5
Dauntless Investment Group, LLC 9.7%
BIGGER CAPITAL FUND L P 6.1%
PALMISANO ROBERT J 5.7%
L1 Capital Global Opportunities M... 4.1%
Blue Owl Capital Holdings LP 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Dauntless Investment Group, LLC
13D/G
9.7%
Reported 13D/G · 26 Feb 2025
$44,372
108,224 shares
$0 26 Feb 2025
BIGGER CAPITAL FUND L P
13D/G
Bigger Michael
6.1%
Reported 13D/G · 06 Jan 2025
$343,000
4,900,000 shares
$0 06 Jan 2025
PALMISANO ROBERT J
13D/G
Robert J Palmisano
5.7%
Reported 13D/G · 25 Jul 2024
$158,550
2,265,000 shares
$0 25 Jul 2024
L1 Capital Global Opportunities Master Fund, Ltd.
13D/G
4.1%
Reported 13D/G · 31 Mar 2025
$32,552
465,029 shares
-$594,648 31 Mar 2025
Blue Owl Capital Holdings LP
13F 13D/G
Company
3.8%
Reported 13D/G · 31 Dec 2024
$1,646,655
3,049,361 shares
— 31 Dec 2024
Priveterra Sponsor, LLC
3/4/5
10%+ Owner
—
mixed-class rows
$138,891,630
14,013,205 shares
mixed-class rows
— 21 Jul 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
15
Shares
1,526,776
Rows available
15
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q2 2026 Across Filers

Q2 2026 holders
22
Q1 2025 holders
15
Holder diff
-7
Investor Q2 2026 Shares Q1 2025 Shares Share Diff Share Chg % Q2 2026 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .